Have a personal or library account? Click to login
Influence of ABCB1 genetic polymorphisms on the antiemetic response to ondansetron-based medication for cisplatin-based chemotherapy in South Indian cancer patients in a tertiary care hospital Cover

Influence of ABCB1 genetic polymorphisms on the antiemetic response to ondansetron-based medication for cisplatin-based chemotherapy in South Indian cancer patients in a tertiary care hospital

Current Issues in Pharmacy and Medical Sciences
Volume 36 (2023): Issue 3 (September 2023)
By: Ayyar Porkodi,  Deepak Gopal Shewade and  Goud Alladi Charanraj  
Open Access
|Sep 2023

Authors

Ayyar Porkodi

porkodia@srmist.edu.in

Pharmacology, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Kattankulathur, India

Deepak Gopal Shewade

Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), India

Goud Alladi Charanraj

Department of Dermatology & STD, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), India
DOI: https://doi.org/10.2478/cipms-2023-0022 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 129 - 135
Submitted on: Jun 9, 2021
|
Accepted on: Feb 10, 2023
|
Published on: Sep 28, 2023
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
genetic polymorphisms,
chemotherapy,
nausea,
ondansetron,
vomiting
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Pharmacology, toxicology,
Pharmacy,
Pharmacy, other

© 2023 Ayyar Porkodi, Deepak Gopal Shewade, Goud Alladi Charanraj, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 36 (2023): Issue 3 (September 2023)Next article